TrialClinical cancer research : an official journal of the American Association for Cancer Research2024

Phase II DORA Study of Olaparib with or without Durvalumab as a Chemotherapy-Free Maintenance Strategy in Platinum-Pretreated Advanced Triple-Negative Breast Cancer.

Tira J Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.